T1	tradename 32 32	
T2	activeingredient 34 46	daunorubicin
T3	nanoparticle 55 63	liposome
T4	routeofadministration 152 163	intravenous
T5	tradename 174 183	DaunoXome
T6	activeingredient 235 247	daunorubicin
T7	nanoparticle 285 295	liposomes)
T8	corecomposition 327 357	distearoylphos-phatidylcholine
T9	corecomposition 362 373	cholesterol
T10	particlediameter 422 428	45 nm.
T11	activeingredient 482 494	daunorubicin
T12	corecomposition 539 581	distearoylphosphatidylcholine:cholesterol:
T13	activeingredient 581 607	daunorubicin. Daunorubicin
T14	chemoclass 614 637	anthracyclineantibiotic
T15	activeingredient 716 728	Daunorubicin
T16	activeingredient 821 833	Daunorubicin
T17	activeingredient 1083 1095	Daunorubicin
T18	nanoparticle 1282 1291	liposome:
T19	nanoparticle 1298 1307	Liposomal
T20	nanoparticle 1445 1454	liposomal
T21	nanoparticle 1546 1556	liposomes.
T22	nanoparticle 1636 1636	
T23	activeingredient 1672 1684	daunorubicin
T24	activeingredient 1715 1727	daunorubicin
T25	nanoparticle 1750 1759	liposomes
T26	corecomposition 1780 1809	distearoylphosphatidylcholine
T27	corecomposition 1821 1833	cholesterol.
T28	nanoparticle 1838 1847	liposomes
T29	activeingredient 1862 1874	daunorubicin
T30	inactiveingredient 1935 1936	,
T31	inactiveingredient 1943 1951	glycine,
T32	inactiveingredient 1961 1987	calcium chloride dihydrate
T33	nanoparticle 2074 2082	liposome
T34	tradename 2180 2180	
T35	nanoparticle 2186 2195	liposomal
T36	activeingredient 2211 2223	daunorubicin
T37	activeingredient 2266 2278	daunorubicin
T38	indication 2287 2294	 tumors
T39	tradename 2352 2352	
T40	activeingredient 2407 2407	
T41	tradename 2588 2597	DaunoXome
T42	activeingredient 2628 2628	
T43	tradename 2798 2808	DaunoXome.
T44	activeingredient 2828 2840	daunorubicin
T45	tradename 2919 2928	DaunoXome
T46	activeingredient 2954 2967	daunorubicin.
T47	activeingredient 3002 3014	daunorubicin
T48	indication 3062 3076	antineoplastic
T49	routeofadministration 3113 3124	intravenous
T50	tradename 3138 3148	DaunoXome,
T51	activeingredient 3168 3180	daunorubicin
T52	dose 3291 3299	40 mg/m2
T53	tradename 3308 3329	DaunoXomeadministered
T54	indication 3376 3405	AIDS-related Kaposi's sarcoma
T55	routeofadministration 3445 3446	,
T56	dose 3447 3455	80 mg/m2
T57	activeingredient 3477 3491	daunorubicinto
T58	indication 3608 3642	AIDS PATIENTS WITHKAPOSI'S SARCOMA
T59	activeingredient 3683 3695	DAUNORUBICIN
T60	tradename 3727 3736	DaunoXome
T61	activeingredient 3812 3812	
T62	tradename 3828 3837	DaunoXome
T63	volumeofdistribution 3888 3894	6.4 L,
T64	clearance 3971 3981	17 mL/min.
T65	activeingredient 4062 4082	daunorubicinexposure
T66	tradename 4113 4122	DaunoXome
T67	activeingredient 4146 4158	daunorubicin
T68	tradename 4211 4220	DaunoXome
T69	activeingredient 4222 4234	daunorubicin
T70	nanoparticle 4250 4250	
T71	plasmahalflife 4265 4275	4.4 hours,
T72	activeingredient 4312 4313	,
T73	tradename 4431 4440	DaunoXome
T74	tradename 4504 4513	DaunoXome
T75	activeingredient 4615 4628	daunorubicin,
T76	routeofadministration 4679 4690	intravenous
T77	tradename 4709 4719	DaunoXome.
T78	tradename 4792 4801	DaunoXome
T79	tradename 4892 4892	
T80	indication 5314 5331	Kaposi's sarcoma,
T81	tradename 5404 5413	DaunoXome
T82	dose 5414 5422	40 mg/m2
T83	dose 5456 5465	10 mg/m2,
T84	routeofadministration 5534 5547	intravenously
T85	frequency 5548 5562	every 2 weeks.
T86	company 6142 6169	Pharmacia &amp; Upjohn Co.,
T87	indication 6247 6263	KAPOSI'S SARCOMA
T88	tradename 6459 6468	DaunoXome
T89	tradename 6588 6600	DaunoXomeand
T90	tradename 6726 6726	
T91	indication 6786 6818	HIV-associated Kaposi's sarcoma.
T92	tradename 6819 6830	DaunoXomeis
T93	indication 6883 6912	HIV-related Kaposi's sarcoma.
T94	tradename 6943 6952	DaunoXome
T95	tradename 7060 7069	DaunoXome
T96	tradename 7118 7118	
T97	tradename 7276 7285	DaunoXome
T98	tradename 7751 7761	DaunoXome.
T99	tradename 8083 8092	DaunoXome
T100	tradename 8167 8176	DaunoXome
T101	dose 8179 8189	320 mg/m2,
T102	dose 8200 8209	160 mg/m2
T103	dose 8302 8311	300 mg/m2
T104	tradename 8473 8483	DaunoXome.
T105	tradename 8529 8538	DaunoXome
T106	dose 8584 8593	160 mg/m2
T107	tradename 8597 8607	DaunoXome.
T108	indication 8625 8642	Kaposi's sarcoma,
T109	dose 8723 8732	340 mg/m2
T110	tradename 8736 8746	DaunoXome.
T111	indication 8756 8780	Kaposi's sarcomapatients
T112	dose 8843 8852	200 mg/m2
T113	dose 8856 8866	2100 mg/m2
T114	dose 8879 8889	320 mg/m2)
T115	tradename 8893 8903	DaunoXome.
T116	indication 8950 8966	Kaposi's sarcoma
T117	tradename 8992 9001	DaunoXome
T118	dose 9038 9047	40 mg/m2,
T119	dose 9121 9133	200 mg/m2 of
T120	tradename 9134 9144	DaunoXome;
T121	adversereaction 9384 9404	back pain, flushing,
T122	adversereaction 9409 9424	chest tightness
T123	tradename 9497 9497	
T124	tradename 9846 9856	DaunoXome,
T125	activeingredient 9959 9985	daunorubicin. Daunorubicin
T126	tradename 10129 10139	DaunoXome,
T127	tradename 10215 10224	DaunoXome
T128	tradename 10371 10371	
T129	tradename 10431 10440	DaunoXome
T130	dose 10499 10520	0.3, 1.0 or 2.0 mg/kg
T131	frequency 10520 10525	/day,
T132	tradename 10601 10610	DaunoXome
T133	dose 10667 10676	2.0 mg/kg
T134	frequency 10676 10680	/day
T135	dose 10789 10798	0.3 mg/kg
T136	frequency 10798 10803	/day.
T137	tradename 10947 10956	DaunoXome
T138	tradename 10987 10987	
T139	tradename 11061 11071	DaunoXome,
T140	tradename 11201 11211	DaunoXome.
T141	tradename 11275 11284	DaunoXome
T142	tradename 11461 11471	DaunoXome(
T143	activeingredient 11471 11483	daunorubicin
T144	nanoparticle 11492 11500	liposome
T145	tradename 11753 11763	DaunoXome.
T146	activeingredient 11845 11858	daunorubicin,
T147	tradename 11883 11893	DaunoXome.
T148	routeofadministration 11971 11982	intravenous
T149	dose 11991 12001	12.5 mg/kg
T150	activeingredient 12002 12014	daunorubicin
T151	activeingredient 12083 12095	Daunorubicin
T152	activeingredient 12300 12312	Daunorubicin
T153	routeofadministration 12313 12324	intravenous
T154	dose 12334 12344	0.25 mg/kg
T155	frequency 12344 12348	/day
T156	tradename 12862 12862	
T157	activeingredient 12872 12885	daunorubicin,
T158	nanoparticle 12915 12916	.
T159	activeingredient 12930 12942	daunorubicin
T160	adversereaction 12947 12970	acute myelosup-pression
T161	activeingredient 13070 13088	daunorubicincauses
T162	adversereaction 13089 13098	alopecia,
T163	adversereaction 13103 13109	nausea
T164	adversereaction 13114 13122	vomiting
T165	activeingredient 13208 13208	
T166	dose 13285 13294	300 mg/m2
T167	adversereaction 13327 13341	cardiomyopathy
T168	adversereaction 13347 13371	congestiveheart failure.
T169	tradename 13388 13398	DaunoXome,
T170	activeingredient 13399 13411	daunorubicin
T171	tradename 13527 13543	DaunoXomeremains
T172	adversereaction 13544 13561	myelosuppression,
T173	indication 13785 13814	HIV-related Kaposi's sarcoma,
T174	tradename 13884 13893	DaunoXome
T175	routeofadministration 13997 13997	
T176	frequency 13998 14012	every 2 weeks.
T177	indication 14172 14206	HIV-associated Kaposi's sarcomaare
T178	adversereaction 14576 14595	back pain, flushing
T179	adversereaction 14600 14615	chest tightness
T180	tradename 14683 14683	
T181	adversereaction 14859 14872	Mild alopecia
T182	tradename 14925 14925	
T183	adversereaction 14930 14947	moderate alopecia
T184	adversereaction 14967 14977	Mildnausea
T185	tradename 15001 15010	DaunoXome
T186	adversereaction 15021 15036	moderate nausea
T187	adversereaction 15060 15073	severe nausea
T188	tradename 15118 15128	DaunoXome,
T189	adversereaction 15129 15141	mildvomiting
T190	tradename 15305 15306	,
T191	tradename 15518 15527	DaunoXome
T192	tradename 15666 15676	DaunoXome,
T193	adversereaction 15720 15747	Injection site inflammation
T194	adversereaction 15764 15825	Hot flushes, hypertension, palpitation, syncope, tachycardia.
T195	tradename 15872 15872	
T196	activeingredient 15874 15886	daunorubicin
T197	nanoparticle 15895 15903	liposome
T198	indication 15934 15950	Kaposi's sarcoma
T199	adversereaction 16025 16243	Pericardialeffusion, pericardial tamponade, ventricular extrasystoles,cardiac arrest, sinus tachycardia, atrial fibrillation, pulmonaryhypertension, myocardial infarction, supraventricular tachy-cardia, angina pectoris
T200	adversereaction 16279 16411	Increased appetite, dysphagia, GI hemorrhage,gastritis, gingival bleeding, hemorrhoids, hepatomegaly,melena, dry mouth, tooth caries
T201	adversereaction 16433 16462	Lymphadenopathy, splenomegaly
T202	adversereaction 16490 16509	Dehydration, thirst
T203	adversereaction 16519 16696	Amnesia, anxiety, ataxia, confusion, convul-sions, emotional lability, abnormal gait, hallucination, hyperkinesia, hypertonia, meningit is, somnolence, abnormal thinking, tremor
T204	adversereaction 16710 16770	Hemoptysis, hiccups, pulmonary infiltration,increased sputum
T205	adversereaction 16777 16810	Folliculitis, seborrhea, dry skin
T206	adversereaction 16827 16897	Conjunctivitis, deafness, earache, eyepain, taste perversion, tinnitus
T207	adversereaction 16910 16937	Dysuria, nocturia, polyuria
T208	tradename 17071 17081	DaunoXome,
T209	adversereaction 17082 17098	myelosuppression
T210	adversereaction 17111 17128	granulocytopenia)
T211	adversereaction 17130 17138	fatigue,
T212	adversereaction 17143 17149	nausea
T213	adversereaction 17161 17162	.
T214	tradename 17197 17197	
T215	routeofadministration 17221 17234	intravenously
T216	dose 17271 17280	40 mg/m2,
T217	frequency 17301 17317	every two weeks.
T218	tradename 18120 18130	DaunoXome.
T219	activeingredient 18167 18179	daunorubicin
T220	tradename 18221 18230	DaunoXome
T221	tradename 18433 18442	DaunoXome
T222	tradename 18493 18493	
T223	tradename 18592 18592	
T224	activeingredient 18602 18614	daunorubicin
T225	activeingredient 18643 18655	daunorubicin
T226	activeingredient 18756 18757	/
T227	tradename 18923 18923	
T228	tradename 19005 19014	DaunoXome
T229	tradename 19156 19165	DaunoXome
T230	tradename 19211 19220	DaunoXome
T231	tradename 19348 19348	
T232	tradename 19357 19366	DaunoXome
T233	routeofadministration 19503 19514	intravenous
T234	tradename 19535 19536	.
T235	tradename 19700 19709	DaunoXome
T236	nanoparticle 19741 19750	liposomes
T237	tradename 19797 19806	DaunoXome
T238	tradename 19981 19981	
T239	nanoparticle 20005 20014	liposomal
T240	tradename 20144 20153	DaunoXome
T241	activeingredient 20163 20175	daunorubicin
T242	activeingredient 20206 20218	daunorubicin
T243	tradename 20256 20265	DaunoXome
T244	tradename 20342 20351	DaunoXome
T245	company 21920 21933	Galen US Inc.
T246	tradename 21994 22003	DaunoXome
T247	tradename 22040 22049	DaunoXome
T248	company 22079 22093	Galen Limited.
T249	company 22109 22123	Galen Limited.
T250	tradename 22243 22252	DaunoXome
T251	activeingredient 22254 22266	daunorubicin
T252	nanoparticle 22276 22284	liposome
T253	adversereaction 22580 22596	myelosuppression
T254	tradename 22611 22620	DaunoXome
T255	adversereaction 22865 22885	back pain, flushing,
T256	adversereaction 22890 22908	chest tightnesshas
T257	tradename 22969 22978	DaunoXome
T258	tradename 23248 23257	DaunoXome
T259	activeingredient 23258 23270	daunorubicin
T260	nanoparticle 23279 23287	liposome
T261	tradename 23327 23327	
T262	activeingredient 23353 23353	
T263	clearance 23371 23390	(mL/min) 17.3 + 6.1
T264	volumeofdistribution 23426 23439	(L) 6.4 + 1.5
T265	plasmahalflife 23474 23489	(h) 4.41 + 2.33
T266	tradename 23564 23573	DaunoXome
T267	tradename 23815 23825	DaunoXome)
T268	tradename 23867 23877	DaunoXome)
T269	tradename 23991 24001	DaunoXome)
T270	tradename 24129 24139	DaunoXome)
T271	tradename 24249 24258	DaunoXome
T272	activeingredient 24259 24271	daunorubicin
T273	nanoparticle 24280 24288	liposome
T274	nanoparticle 24319 24328	liposomes
T275	tradename 24340 24340	
T276	particlediameter 24351 24363	35 and65 nm.
T277	tradename 24497 24506	DaunoXome
T278	adversereaction 24563 24574	Neutropenia
T279	adversereaction 24605 24616	Neutropenia
T280	adversereaction 24923 24931	Alopecia
T281	adversereaction 24966 24976	Neuropathy
T282	activeingredient 25089 25101	daunorubicin
T283	tradename 25111 25120	DaunoXome
T284	adversereaction 25145 25151	Nausea
T285	adversereaction 25166 25173	Fatigue
T286	adversereaction 25188 25193	Fever
T287	adversereaction 25208 25216	Diarrhea
T288	adversereaction 25231 25236	Cough
T289	adversereaction 25251 25258	Dyspnea
T290	adversereaction 25273 25281	Headache
T291	adversereaction 25296 25314	Allergic Reactions
T292	adversereaction 25329 25343	Abdominal Pain
T293	adversereaction 25358 25366	Anorexia
T294	adversereaction 25381 25389	Vomiting
T295	adversereaction 25404 25410	Rigors
T296	adversereaction 25425 25434	Back Pain
T297	adversereaction 25448 25466	Increased Sweating
T298	adversereaction 25481 25491	Neuropathy
T299	adversereaction 25506 25514	Rhinitis
T300	adversereaction 25528 25533	Edema
T301	adversereaction 25546 25556	Chest Pain
T302	adversereaction 25569 25579	Depression
T303	adversereaction 25592 25599	Malaise
T304	adversereaction 25613 25623	Stomatitis
T305	adversereaction 25636 25644	Alopecia
T306	adversereaction 25658 25667	Dizziness
T307	adversereaction 25680 25689	Sinusitis
T308	adversereaction 25702 25712	Arthralgia
T309	adversereaction 25725 25737	Constipation
T310	adversereaction 25751 25758	Myalgia
T311	adversereaction 25772 25780	Pruritus
T312	adversereaction 25794 25802	Insomnia
T313	adversereaction 25851 25859	Tenesmus
T314	adversereaction 25872 25887	Abnormal vision
